Skip to main content
OpenTrials
Completed

NCT Number: NCT00639379

Comparison of Two Toric Contact Lenses on Current Toric Wearers

The purpose of this study is to evaluate and compare the clinical performance of two toric contact lenses amongst 110 subjects, 2-week, single masked (subject), daily wear, randomized, bilateral, crossover study; 4 weeks duration. Hypotheses include equal or better performance of the test lens over the control lenses for comfort, vision, and toric fit characteristics as well as corneal integrity

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ted Brink and Associates, Jacksonville, Florida, United States

Loading trial locations.

About this study

Up to 7 sites in the US will participate. Each investigator will have both test and control lens types. There will be a maximum of 6 scheduled visits:

Visit 1: Habitual lens evaluation / Baseline / Trial fitting Visit 2: Dispensing (to be combined with Visit 1 where possible), Visit 3: Questionnaire only (no exam) 7 days (±2) after dispensing, Visit 4: 2 week follow-up 14 days (±3) after dispensing, and dispense second lens type, Visit 5: Questionnaire only (no exam) 7 days (±2) after 2nd lens dispense, Visit 6: 2 week follow-up 14 days (±3) after 2nd lens dispense

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be at least 18 and less than or equal to 45 years of age, have a need for vision correction and wear contact lenses in BOTH eyes (monovision or uni-ocular fitting is NOT allowed).
  • Be able to read J1 at near WITHOUT the aid of a near addition over the distance prescription.
  • Be a currently successful wearer for at least 3 months of B&L SofLens 66 Toric hydrogel lenses.
  • Be able and willing to adhere to the instructions set forth in the protocol.
  • Agree to wear their contact lenses in both eyes on a daily wear schedule for at least 8 hours per day every day during the study.
  • Have a distance spectacle spherical component between -1.00 D and -5.25 D with cylinder in the range of 0.75 D to 2.25 D and cylinder axis within 10 ° of the vertical and within 30° of the horizontal in both eyes (when the subject's prescription is presented in minus cylinder form).
  • Have a best corrected manifest refraction visual acuity of at least 20/25 or better in each eye.
  • Be in good general health, based on his/her knowledge.
  • Must be given an explanation of the study objectives, lens and solutions usage requirements and visit schedule. The subject must read, indicate understanding of and agree to begin participation in the clinical study. The subject must then sign the Informed Consent Form in the presence of the Investigator or their designee.

Exclusion criteria

  • Presbyopic or has the need for a near add for reading.
  • Previous refractive surgery; current or previous orthokeratology treatment.
  • Aphakia, keratoconus or a highly irregular cornea.
  • The presence of ocular or systemic disease or has the need for medication (ocular or systemic) which might interfere with contact lens wear or which would cause the lenses to be removed more than twice a day. (e.g., Sjögren's syndrome, type II diabetes, allergies).
  • A known history of corneal hypoesthesia (reduced corneal sensitivity.)
  • Anterior uveitis or iritis (past or present).
  • A history of recurrent erosions, corneal infiltrates corneal ulcer or fungal infections.
  • Clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations or infections of the eye, eyelids, or associated structures.
  • Slit lamp findings that would contraindicate contact lens wear such as:
  • Pathological dry eye or associated findings
  • Pterygium or corneal scars within the visual axis
  • Neovascularization >1mm in from the limbus
  • History of giant papillary conjunctivitis (GPC) worse than Grade 2
  • Meibomian gland dysfunction, blepharitis, or seborrhoeic dermatitis
  • Current pregnancy or lactation (to the best of the subject's knowledge).
  • Actively participating in another clinical study at any time during this study.

Treatment and study plan

senofilcon A toric

Device

silicone hydrogel toric lens, 2 wk replacement, daily wear

Other names: ACUVUE OASYS

alphafilcon A toric

Device

hydrogel toric lens, 2 wk replacement, daily wear

Other names: SofLens Toric

Primary outcomes

  1. Lens Orientation Within 5 Degrees

    Time frame: 1 minute after insertion

    Number of eyes with lens orientation within 5 degrees of optimal orientation within 1 minute of contact lens insertion.

  2. Lens Stability

    Time frame: 10-15 minutes after insertion

    Number of eyes with the amount of rotation induced from a blink within 5 degrees of settled orientation.

  3. Subjective Lens Comfort

    Time frame: 1 and 2 weeks

    A weighted combined score calculated from individual comfort-related questions asked on a 1-5 scale: 1=most negative response to 5=most positive response, was used to derive comfort outcomes. The analysis shows the difference in outcome between the test and control. >0=comfortable, <0=uncomfortable.

  4. Subjective Vision

    Time frame: 1 and 2 weeks

    A weighted combined score calculated from individual vision-related questions asked on a 1-5 scale: 1=most negative response to 5=most positive response, was used to derive vision outcomes. The analysis shows the difference in outcome between the test and control. >0=satisfactory vision, <0=unsatisfactory vision.

  5. Overall Corneal Staining

    Time frame: after 2 weeks use

    Corneal staining measured using the National Eye Institute grading scale of grade 0 = normal, grade 1 = mild, grade 2 = moderate, grade 3 = severe.

Sponsors and collaborators

Lead sponsor

Johnson & Johnson Vision Care, Inc.

Industry

Registry information

Official study title

A Multi-Center, Subject Masked, Randomized, Two Week Crossover Design, Investigation of the Acuvue Cypress Toric Silicone Hydrogel Lens Compared to the Bausch & Lomb SofLens66® Toric Hydrophilic Lens

Important dates

Study start
2008
Primary completion
2008
Study completion
2008
First posted
Mar 20, 2008
Registry last updated
May 21, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.